Search research articles
Contact Us
Filters
Showing results (241-250 of 531) with videos related to
Page
of 54
Sort By:
The Journal of Antimicrobial Chemotherapy
|
April 1, 1990
Nephrotoxicity of vancomycin, alone and with an aminoglycoside
M J Rybak, L M Albrecht, S C Boike, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|
July 16, 2014
Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Pulmonary Exacerbation in a Pediatric Cystic Fibrosis Patient
Leah Molloy, Ashley Hall Snyder, Ruma Srivastava, et al.
Antimicrobial Agents and Chemotherapy
|
August 22, 2012
Evaluation of the novel combination of high-dose daptomycin plus trimethoprim-sulfamethoxazole against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus using an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations
Molly E Steed, Brian J Werth, Cortney E Ireland, et al.
The Journal of Antimicrobial Chemotherapy
|
January 1, 1986
Clinical use and toxicity of high-dose tobramycin in patients with pseudomonal endocarditis
M J Rybak, S C Boike, D P Levine, et al.
Clinical Pharmacy
|
May 1, 1985
Evaluation of the vancomycin-clearance:creatinine-clearance relationship for predicting vancomycin dosage
G R Matzke, J M Kovarik, M J Rybak, et al.
Infectious Diseases and Therapy
|
November 7, 2015
Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia with Ceftaroline Fosamil in a Patient with Inhalational Thermal Injury
Janie Faris, Ryan P Mynatt, Ashley D Hall Snyder, et al.
Open Forum Infectious Diseases
|
September 18, 2023
Weighing the Odds: Novel β-Lactam/β-Lactamase Inhibitor Use in Hospital-Acquired and Ventilator-Associated <i>Pseudomonas aeruginosa</i> Pneumonia for Patients Who Are Morbidly Obese
Ashlan J Kunz Coyne, Carolina Orzol, Michael P Veve, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|
November 1, 1982
[Surgical treatment of goiter in patients over 60]
M Róg, Z Puchalski, Z Piotrowski, et al.
Antimicrobial Agents and Chemotherapy
|
March 30, 2006
Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model
Kerry L LaPlante, Michael J Rybak, Kimberly D Leuthner, et al.
Diagnostic Microbiology and Infectious Disease
|
May 30, 2018
Impact of cefazolin co-administration with vancomycin to reduce development of vancomycin-intermediate Staphylococcus aureus
Nivedita B Singh, Juwon Yim, Seyedehameneh Jahanbakhsh, et al.
Page
of 54
Search research articles
Search
Showing results (241-250 of 531) with videos related to
Sort By:
Page
of 54
The Journal of Antimicrobial Chemotherapy
|
April 1, 1990
Nephrotoxicity of vancomycin, alone and with an aminoglycoside
M J Rybak, L M Albrecht, S C Boike, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|
July 16, 2014
Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Pulmonary Exacerbation in a Pediatric Cystic Fibrosis Patient
Leah Molloy, Ashley Hall Snyder, Ruma Srivastava, et al.
Antimicrobial Agents and Chemotherapy
|
August 22, 2012
Evaluation of the novel combination of high-dose daptomycin plus trimethoprim-sulfamethoxazole against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus using an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations
Molly E Steed, Brian J Werth, Cortney E Ireland, et al.
The Journal of Antimicrobial Chemotherapy
|
January 1, 1986
Clinical use and toxicity of high-dose tobramycin in patients with pseudomonal endocarditis
M J Rybak, S C Boike, D P Levine, et al.
Clinical Pharmacy
|
May 1, 1985
Evaluation of the vancomycin-clearance:creatinine-clearance relationship for predicting vancomycin dosage
G R Matzke, J M Kovarik, M J Rybak, et al.
Infectious Diseases and Therapy
|
November 7, 2015
Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia with Ceftaroline Fosamil in a Patient with Inhalational Thermal Injury
Janie Faris, Ryan P Mynatt, Ashley D Hall Snyder, et al.
Open Forum Infectious Diseases
|
September 18, 2023
Weighing the Odds: Novel β-Lactam/β-Lactamase Inhibitor Use in Hospital-Acquired and Ventilator-Associated <i>Pseudomonas aeruginosa</i> Pneumonia for Patients Who Are Morbidly Obese
Ashlan J Kunz Coyne, Carolina Orzol, Michael P Veve, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|
November 1, 1982
[Surgical treatment of goiter in patients over 60]
M Róg, Z Puchalski, Z Piotrowski, et al.
Antimicrobial Agents and Chemotherapy
|
March 30, 2006
Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model
Kerry L LaPlante, Michael J Rybak, Kimberly D Leuthner, et al.
Diagnostic Microbiology and Infectious Disease
|
May 30, 2018
Impact of cefazolin co-administration with vancomycin to reduce development of vancomycin-intermediate Staphylococcus aureus
Nivedita B Singh, Juwon Yim, Seyedehameneh Jahanbakhsh, et al.
Page
of 54